Developer docs
API playgroundTry for free, no card

Search company profiles

Sohn Conference Foundation

Full company profile

uuid000vhf9

Namestring
Sohn Conference Foundation
Legal namestring
Ira Sohn Conference Foundation, Inc.
Company typeenum
Private
Founded yearint
1993
Descriptiontext

The Sohn Conference Foundation is a New York-based non-profit (legal name: Ira Sohn Conference Foundation, Inc.) founded in 1993 following the death of Wall Street trader Ira Sohn from cancer. The Foundation's core activity is hosting annual investment conferences in New York and globally (Hong Kong, Montreal, Monaco, San Francisco, Australia, London, Tel Aviv), where successful hedge fund managers and institutional investors present high-conviction investment ideas to audiences of more than 1,000 attendees per event. Revenue is generated through presenter fees, attendee fees, sponsor commitments, and charitable donations.

The Foundation's philanthropic arm operates through a four-pronged grant-making approach: inspiring scientific research collaborations, investing in state-of-the-art lab technologies (e.g., microscopes, DNA sequencers), funding early-career physician-scientist fellowships, and supporting patient quality-of-care initiatives. Its flagship program is the Pershing Square Sohn Cancer Research Alliance (a partnership with the Pershing Square Foundation), which in 2026 awarded $9 million in $750,000 grants to 13 early-career cancer researchers, building on a 13-year track record of $58 million to 90 scientists at 24 institutions. The Foundation also co-funds the Damon Runyon-Sohn Pediatric Cancer Fellowship Award.

In 2026, the Foundation introduced an Emerging Company Pavilion at the flagship New York conference, curating 8-10 high-growth public companies for direct investor exposure. Over its 30-year history, the Foundation has raised more than $150 million and holds no equity, debt, or traditional ownership structure, operating as a 501(c)-style charity under New York State governance.

Short descriptiontext

The Sohn Conference Foundation is a New York-based non-profit, founded in 1993, that hosts annual global investment conferences to raise funds for cancer research. It directs grants through partnerships like the Pershing Square Sohn Cancer Research Alliance and Damon Runyon-Sohn Fellowship, having awarded over $58M to early-career scientists.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment conferences, cancer research grants, pediatric cancer funding, philanthropic foundation, nonprofit healthcare
Industry3 codes
1Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryYes
2Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
3Scholarship & Fellowship Foundations and Trusts
CodeEDADAHACPrimaryNo
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Membership Organizations8600
Product category
Philanthropic Foundation Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Charitable Donations
TypeGrants Donations
Description

The Foundation receives cash charitable donations from individuals and organizations supporting its mission to fund cancer research and public health initiatives.

sohnconference.org
2Conference Fees
TypeProfessional Services
Description

The Foundation receives fees from presenters, sponsors, and participants who attend the Sohn Investment Conferences.

sohnconference.org
3Event Sponsorships
TypeGrants Donations
Description

Initial sponsor commitments for annual global conferences generate revenue to support foundation operations and grant-making.

sohnconference.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Marketing or Sales, Personnel, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Pershing Square Sohn Cancer Research Alliance
Description

A research alliance that awards the Pershing Square Sohn Cancer Prize to early-career cancer researchers, providing $750,000 grants for innovative cancer research projects.

pulse2.com
Core offering1 text field

The Sohn Conference Foundation is a nonprofit that hosts annual investment conferences globally, where leading institutional investors present high-conviction investment ideas. Conference fees, sponsorships, and donations fund cancer research grants through programs such as the Pershing Square Sohn Cancer Prize, the Pershing Square Sohn Cancer Research Alliance, and the Damon Runyon-Sohn Pediatric Cancer Fellowship Award.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • $9 million awarded in 2026 through Pershing Square Sohn Cancer Prize with $750,000 grants to 13 innovators
+2 more records
Product overview1 text field

The Sohn Conference Foundation is a philanthropic organization that hosts annual investment conferences globally (New York, Hong Kong, Montreal, Monaco, San Francisco, Australia, London, and Tel Aviv) and funds cancer research initiatives. The Foundation's core offerings include the Sohn Investment Conferences where leading investors present investment ideas, the Pershing Square Sohn Cancer Prize supporting early-career cancer researchers with $750,000 grants, the Damon Runyon-Sohn Pediatric Cancer Fellowship Award, and the Emerging Company Pavilion showcasing high-growth companies. Over $150 million has been raised in 30 years, with the Foundation's four-pronged approach focusing on inspiring cutting-edge research collaborations, investing in state-of-the-art technology, developing the next generation of physician scientists, and promoting quality of care for patients.

Product and service3 records
1Sohn Investment Conferences
CategoryInvestment Conferences
Description

Annual investment conferences held globally in New York, Hong Kong, Montreal, Monaco, San Francisco, Australia, London, and Tel Aviv, bringing together leading institutional investors to present investment ideas and support the Foundation's mission.

2Pershing Square Sohn Cancer Prize
CategoryCancer Research Grants
Description

Annual prize awarding $750,000 grants to early-career cancer researchers for innovative cancer research projects. In 2026, 13 winners received $9 million in total funding.

3Damon Runyon-Sohn Pediatric Cancer Fellowship Award
CategoryPediatric Cancer Fellowships
Description

Fellowship program awarding nearly $500,000 to $1 million per recipient to fund innovative pediatric cancer research projects by young scientists.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

The Pershing Square Sohn Cancer Research Alliance is a collaboration between the Pershing Square Foundation and the Sohn Conference Foundation. In 2026, the Alliance doubled its funding commitment, awarding 13 winners of the Pershing Square Sohn Cancer Prize with $750,000 grants each for early-career cancer research. Over its 13-year history, the Alliance has awarded $58 million to 90 scientists at 24 institutions, supporting research in immunotherapy, AI-driven protein design, RNA-targeting therapies, and novel cancer drug development.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

The Damon Runyon-Sohn Pediatric Cancer Fellowship Award supports outstanding young scientists addressing critical funding shortages in pediatric cancer research. Awards commit nearly $500,000 to $1 million per recipient to fund innovative research projects.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global nonprofit that convenes major investor, policy, and health conferences (including the Milken Conference). Comparable hybrid model combining marquee conferences with philanthropic and research programs.

TypeDirect peer
Description

Membership-based peer learning and investment idea community for ultra-high-net-worth investors. Comparable as a community of wealthy investors consuming curated investment content, though without the philanthropic mission.

TypeDirect peer
Description

Direct partner via the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. Compares as a fellow cancer research grantmaker focused on early-career scientists and innovative research.

TypeDirect peer
Description

Large disease-specific research foundation that funds high-risk, high-reward early-stage research and adjacent technology. Comparable as a similarly positioned single-disease research funder with substantial annual grantmaking and brand-driven fundraising.

TypeDirect peer
Description

New York-based poverty-fighting foundation that convenes Wall Street and finance leaders to raise funds for nonprofit programs. Comparable as a New York-based foundation that monetizes finance-community engagement for charitable impact.

TypeDirect peer
Description

Major U.S. cancer research grantmaker founded in memory of Jim Valvano. Comparable as a similarly scaled disease-specific research funder that channels donations from sports and entertainment audiences into cancer research grants.

TypeDirect peer
Description

Media-driven cancer research funder that raises large sums through high-profile entertainment-industry events and funds collaborative research teams. Comparable event-driven, mission-aligned fundraising model.

TypeBroad incumbent
Description

Largest U.S. cancer-focused nonprofit with broad research, patient support, and advocacy mandates. Comparable as a far larger incumbent in the same cancer research grantmaking space.

TypeDirect peer
Description

Pediatric cancer research and support foundation. Comparable as a smaller, pediatric-cancer-focused peer with a similar grantmaking and research-funding model.

TypeDirect peer
Description

Co-funder of the Pershing Square Sohn Cancer Research Alliance and a New York-based philanthropic foundation. Directly comparable as a strategic funding partner in the Foundation's largest grantmaking program.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sohn Conference Foundation

Philanthropic Foundation Servicessohnconference.org

The Sohn Conference Foundation is a New York-based non-profit, founded in 1993, that hosts annual global investment conferences to raise funds for cancer research. It directs grants through partnerships like the Pershing Square Sohn Cancer Research Alliance and Damon Runyon-Sohn Fellowship, having awarded over $58M to early-career scientists.

What Sohn Conference Foundation does

The Sohn Conference Foundation is a New York-based non-profit (legal name: Ira Sohn Conference Foundation, Inc.) founded in 1993 following the death of Wall Street trader Ira Sohn from cancer. The Foundation's core activity is hosting annual investment conferences in New York and globally (Hong Kong, Montreal, Monaco, San Francisco, Australia, London, Tel Aviv), where successful hedge fund managers and institutional investors present high-conviction investment ideas to audiences of more than 1,000 attendees per event. Revenue is generated through presenter fees, attendee fees, sponsor commitments, and charitable donations.

The Foundation's philanthropic arm operates through a four-pronged grant-making approach: inspiring scientific research collaborations, investing in state-of-the-art lab technologies (e.g., microscopes, DNA sequencers), funding early-career physician-scientist fellowships, and supporting patient quality-of-care initiatives. Its flagship program is the Pershing Square Sohn Cancer Research Alliance (a partnership with the Pershing Square Foundation), which in 2026 awarded $9 million in $750,000 grants to 13 early-career cancer researchers, building on a 13-year track record of $58 million to 90 scientists at 24 institutions. The Foundation also co-funds the Damon Runyon-Sohn Pediatric Cancer Fellowship Award.

In 2026, the Foundation introduced an Emerging Company Pavilion at the flagship New York conference, curating 8-10 high-growth public companies for direct investor exposure. Over its 30-year history, the Foundation has raised more than $150 million and holds no equity, debt, or traditional ownership structure, operating as a 501(c)-style charity under New York State governance.

Sohn Conference Foundation firmographics

Firmographics
Name
Sohn Conference Foundation
Legal name
Ira Sohn Conference Foundation, Inc.
Website
https://sohnconference.org
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
1–10 employees
Short description
The Sohn Conference Foundation is a New York-based non-profit, founded in 1993, that hosts annual global investment conferences to raise funds for cancer research. It directs grants through partnerships like the Pershing Square Sohn Cancer Research Alliance and Damon Runyon-Sohn Fellowship, having awarded over $58M to early-career scientists.
Ownership category
akta.pro rank

Sohn Conference Foundation industry classification

Industry
Product category
Philanthropic Foundation Services
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)
akta.pro secondary industries
Research & Science Grantmaking Foundations (BPAGAKAI), Scholarship & Fellowship Foundations and Trusts (EDADAHAC)

Keywords

  • Investment conferences
  • Cancer research grants
  • Pediatric cancer funding
  • Philanthropic foundation
  • Nonprofit healthcare

Where Sohn Conference Foundation is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sohn Conference Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Marketing or Sales, Personnel, Others

Revenue model

  1. Charitable Donations: The Foundation receives cash charitable donations from individuals and organizations supporting its mission to fund cancer research and public health initiatives.
  2. Conference Fees: The Foundation receives fees from presenters, sponsors, and participants who attend the Sohn Investment Conferences.
  3. Event Sponsorships: Initial sponsor commitments for annual global conferences generate revenue to support foundation operations and grant-making.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Sohn Conference Foundation product offering

Product offering

Core offering

The Sohn Conference Foundation is a nonprofit that hosts annual investment conferences globally, where leading institutional investors present high-conviction investment ideas. Conference fees, sponsorships, and donations fund cancer research grants through programs such as the Pershing Square Sohn Cancer Prize, the Pershing Square Sohn Cancer Research Alliance, and the Damon Runyon-Sohn Pediatric Cancer Fellowship Award.

Product overview

The Sohn Conference Foundation is a philanthropic organization that hosts annual investment conferences globally (New York, Hong Kong, Montreal, Monaco, San Francisco, Australia, London, and Tel Aviv) and funds cancer research initiatives. The Foundation's core offerings include the Sohn Investment Conferences where leading investors present investment ideas, the Pershing Square Sohn Cancer Prize supporting early-career cancer researchers with $750,000 grants, the Damon Runyon-Sohn Pediatric Cancer Fellowship Award, and the Emerging Company Pavilion showcasing high-growth companies. Over $150 million has been raised in 30 years, with the Foundation's four-pronged approach focusing on inspiring cutting-edge research collaborations, investing in state-of-the-art technology, developing the next generation of physician scientists, and promoting quality of care for patients.

Differentiator

Problem solved

Functional benefit

Brands

  • Pershing Square Sohn Cancer Research Alliance: A research alliance that awards the Pershing Square Sohn Cancer Prize to early-career cancer researchers, providing $750,000 grants for innovative cancer research projects.

Products and services

  • Sohn Investment Conferences Annual investment conferences held globally in New York, Hong Kong, Montreal, Monaco, San Francisco, Australia, London, and Tel Aviv, bringing together leading institutional investors to present investment ideas and support the Foundation's mission.
  • Pershing Square Sohn Cancer Prize Annual prize awarding $750,000 grants to early-career cancer researchers for innovative cancer research projects. In 2026, 13 winners received $9 million in total funding.
  • Damon Runyon-Sohn Pediatric Cancer Fellowship Award Fellowship program awarding nearly $500,000 to $1 million per recipient to fund innovative pediatric cancer research projects by young scientists.

Quantifiable outcome

  • $9 million awarded in 2026 through Pershing Square Sohn Cancer Prize with $750,000 grants to 13 innovators
  • +2 more outcomes

Companies that use Sohn Conference Foundation

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Sohn Conference Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sohn Conference Foundation partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • Pershing Square FoundationcoreStrategic or Co-development Partner · 7 May 2026The Pershing Square Sohn Cancer Research Alliance is a collaboration between the Pershing Square Foundation and the Sohn Conference Foundation. In 2026, the Alliance doubled its funding commitment, awarding 13 winners of the Pershing Square Sohn Cancer Prize with $750,000 grants each for early-career cancer research. Over its 13-year history, the Alliance has awarded $58 million to 90 scientists at 24 institutions, supporting research in immunotherapy, AI-driven protein design, RNA-targeting therapies, and novel cancer drug development.
  • Damon Runyon Cancer Research FoundationflagshipStrategic or Co-development Partner · 1 January 2026The Damon Runyon-Sohn Pediatric Cancer Fellowship Award supports outstanding young scientists addressing critical funding shortages in pediatric cancer research. Awards commit nearly $500,000 to $1 million per recipient to fund innovative research projects.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Sohn Conference Foundation competitors and assessment

Company assessment

Broad incumbents

  • Milken Institute: Global nonprofit that convenes major investor, policy, and health conferences (including the Milken Conference). Comparable hybrid model combining marquee conferences with philanthropic and research programs.
  • American Cancer Society: Largest U.S. cancer-focused nonprofit with broad research, patient support, and advocacy mandates. Comparable as a far larger incumbent in the same cancer research grantmaking space.

Direct peers

  • Tiger 21: Membership-based peer learning and investment idea community for ultra-high-net-worth investors. Comparable as a community of wealthy investors consuming curated investment content, though without the philanthropic mission.
  • Damon Runyon Cancer Research Foundation: Direct partner via the Damon Runyon-Sohn Pediatric Cancer Fellowship Award. Compares as a fellow cancer research grantmaker focused on early-career scientists and innovative research.
  • Michael J. Fox Foundation for Parkinson's Research: Large disease-specific research foundation that funds high-risk, high-reward early-stage research and adjacent technology. Comparable as a similarly positioned single-disease research funder with substantial annual grantmaking and brand-driven fundraising.
  • Robin Hood Foundation: New York-based poverty-fighting foundation that convenes Wall Street and finance leaders to raise funds for nonprofit programs. Comparable as a New York-based foundation that monetizes finance-community engagement for charitable impact.
  • V Foundation for Cancer Research: Major U.S. cancer research grantmaker founded in memory of Jim Valvano. Comparable as a similarly scaled disease-specific research funder that channels donations from sports and entertainment audiences into cancer research grants.
  • Stand Up To Cancer: Media-driven cancer research funder that raises large sums through high-profile entertainment-industry events and funds collaborative research teams. Comparable event-driven, mission-aligned fundraising model.
  • CureSearch for Children's Cancer: Pediatric cancer research and support foundation. Comparable as a smaller, pediatric-cancer-focused peer with a similar grantmaking and research-funding model.
  • Pershing Square Foundation: Co-funder of the Pershing Square Sohn Cancer Research Alliance and a New York-based philanthropic foundation. Directly comparable as a strategic funding partner in the Foundation's largest grantmaking program.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

Sohn Conference Foundation social profiles

Digital presence

Sohn Conference Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sohn Conference Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Sohn Conference Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sohn Conference Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sohn Conference Foundation

What does Sohn Conference Foundation do?

The Sohn Conference Foundation is a nonprofit that hosts annual investment conferences globally, where leading institutional investors present high-conviction investment ideas. Conference fees, sponsorships, and donations fund cancer research grants through programs such as the Pershing Square Sohn Cancer Prize, the Pershing Square Sohn Cancer Research Alliance, and the Damon Runyon-Sohn Pediatric Cancer Fellowship Award.

Is Sohn Conference Foundation a public or private company?

Sohn Conference Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Sohn Conference Foundation founded?

Sohn Conference Foundation was founded in 1993. It employs 1 to 10 people.

Where is Sohn Conference Foundation based?

Sohn Conference Foundation is headquartered in New York, United States, in the North America region.

How does Sohn Conference Foundation make money?

Three revenue lines are on record. Charitable Donations are the primary driver. The others are conference Fees and event Sponsorships.

Who are Sohn Conference Foundation's main competitors?

Broad incumbents on record are Milken Institute and American Cancer Society. Direct peers are Tiger 21, Damon Runyon Cancer Research Foundation, Michael J. Fox Foundation for Parkinson's Research, Robin Hood Foundation, V Foundation for Cancer Research, Stand Up To Cancer, CureSearch for Children's Cancer and Pershing Square Foundation.

Does Sohn Conference Foundation have an API?

No public API is recorded for Sohn Conference Foundation.

What industry is Sohn Conference Foundation in?

Sohn Conference Foundation's product category is Philanthropic Foundation Services. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGAKAI, Research & Science Grantmaking Foundations. Its NAICS code is 813211 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WsjDarts Are Beating the Ira Sohn Investing ProsJeffrey Gundlach's comments at the Sohn Conference in New York are cited as evidence that professional investors consistently underperform random stock selection. The article suggests that investors would have achieved better results by picking companies randomly rather than following Wall Street experts.WsjCan Throwing Darts Beat Hedge-Fund Managers’ Stock Picks?The Wall Street Journal's Heard on the Street team will pit 10 dart-based stock picks against 12 hedge-fund picks from the Sohn Investment Conference. The contest, following the 1988-2002 Journal darts, will be tallied every three months until next year's event.Business InsiderWatch 24-year-old chess-champ Magnus Carlsen destroy 3 players simultaneously — while blindfoldedMagnus Carlsen defeated three opponents simultaneously while playing blindfolded in a timed match at the Sohn Conference in New York City on May 4. His challengers were financier J. Christopher Flowers, Paul Hoffman, and actor Gbenga Akinnagbe, who were not blindfolded. The conference raised funds for pediatric cancer research.GlobeNewswireSohn Investment Idea Contest Kicks Off Ahead of 20th Annual Sohn Investment ConferenceThe Sohn Conference Foundation launched an Investment Idea Contest with Bloomberg, open to individuals with ideas for securities over $1 billion. The winner will present at the 20th Annual Sohn Investment Conference on May 4, 2015, with entries closing April 28. Last year's winner pitched Fiat as undervalued.Business InsiderSome of Wall Street's most brilliant hedge fund minds are judging the investment idea contest of the yearThe Sohn Conference Foundation launched its Investment Idea Contest, open to individuals with investment theses for securities over $1 billion in market cap. A panel including Bill Ackman, David Einhorn, Joel Greenblatt, Seth Klarman, and Michael Price will judge entries, with the contest closing April 28. The winner presents at the May 4 conference in New York.GlobeNewswireWorld's Leading Investors to Unveil New Ideas at 20th Annual Sohn Investment ConferenceThe Sohn Conference Foundation announced its 20th Annual Sohn Investment Conference speaker lineup for May 4, 2015, in New York City. The event, held with Bloomberg, has raised over $50 million for pediatric cancer research. Next Wave Sohn will relocate to Alice Tully Hall due to demand.GlobeNewswireSohn Conference Foundation and Capitalize for Kids Partner to Host Canada's Premier Investment Forum in Toronto to Support Children's Health InitiativesThe Sohn Conference Foundation and Capitalize for Kids will host the inaugural Sohn Conference Canada in Toronto on October 23-24, 2014, bringing together investors to present ideas and raise funds. All proceeds will support children's health initiatives and pediatric cancer research, with the foundation having raised over $50 million.GlobeNewswireWorld's Preeminent Investors to Speak at 19th Annual Sohn Investment ConferenceThe Sohn Conference Foundation announced the speaker lineup for its 19th Annual Sohn Investment Conference on May 5, 2014, in New York City. The event will feature prominent investors and a new initiative, Next Wave Sohn, showcasing emerging managers. The conference raises funds for pediatric cancer research, having raised over $50 million since 1995.GlobeNewswireSohn Conference Foundation Announces Annual Investment Idea ContestThe Sohn Conference Foundation announced its annual Investment Idea Contest, seeking a publicly traded security with market cap of $1 billion or greater. Entries are due April 29, and the winner will present at the May 5 conference in New York City. The contest is judged by a panel including Michael Price, Bill Ackman, David Einhorn, Seth Klarman, and Joel Greenblatt.GlobeNewswireSohn Conference Foundation and Bloomberg Team Up to Produce Renowned Investment ConferencesThe Sohn Conference Foundation and Bloomberg LINK announced a partnership to produce upcoming Sohn Investment Conferences, starting with the 19th annual New York event on May 5, 2014. Bloomberg LINK will apply its production expertise to the 2014 New York and London conferences, with speaker lineups and new elements to be announced.